245 related articles for article (PubMed ID: 17213309)
21. Triple-color FRET analysis reveals conformational changes in the WIP-WASp actin-regulating complex.
Fried S; Reicher B; Pauker MH; Eliyahu S; Matalon O; Noy E; Chill J; Barda-Saad M
Sci Signal; 2014 Jun; 7(331):ra60. PubMed ID: 24962707
[TBL] [Abstract][Full Text] [Related]
22. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP.
Lanzi G; Moratto D; Vairo D; Masneri S; Delmonte O; Paganini T; Parolini S; Tabellini G; Mazza C; Savoldi G; Montin D; Martino S; Tovo P; Pessach IM; Massaad MJ; Ramesh N; Porta F; Plebani A; Notarangelo LD; Geha RS; Giliani S
J Exp Med; 2012 Jan; 209(1):29-34. PubMed ID: 22231303
[TBL] [Abstract][Full Text] [Related]
23. WIP is critical for T cell responsiveness to IL-2.
Le Bras S; Massaad M; Koduru S; Kumar L; Oyoshi MK; Hartwig J; Geha RS
Proc Natl Acad Sci U S A; 2009 May; 106(18):7519-24. PubMed ID: 19359486
[TBL] [Abstract][Full Text] [Related]
24. A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization.
Moreau V; Frischknecht F; Reckmann I; Vincentelli R; Rabut G; Stewart D; Way M
Nat Cell Biol; 2000 Jul; 2(7):441-8. PubMed ID: 10878810
[TBL] [Abstract][Full Text] [Related]
25. Formation of a WIP-, WASp-, actin-, and myosin IIA-containing multiprotein complex in activated NK cells and its alteration by KIR inhibitory signaling.
Krzewski K; Chen X; Orange JS; Strominger JL
J Cell Biol; 2006 Apr; 173(1):121-32. PubMed ID: 16606694
[TBL] [Abstract][Full Text] [Related]
26. Wiskott-Aldrich syndrome protein is a key regulator of the phagocytic cup formation in macrophages.
Tsuboi S; Meerloo J
J Biol Chem; 2007 Nov; 282(47):34194-203. PubMed ID: 17890224
[TBL] [Abstract][Full Text] [Related]
27. WIP null mice display a progressive immunological disorder that resembles Wiskott-Aldrich syndrome.
Curcio C; Pannellini T; Lanzardo S; Forni G; Musiani P; Antón IM
J Pathol; 2007 Jan; 211(1):67-75. PubMed ID: 17086554
[TBL] [Abstract][Full Text] [Related]
28. The rat homologue of Wiskott-Aldrich syndrome protein (WASP)-interacting protein (WIP) associates with actin filaments, recruits N-WASP from the nucleus, and mediates mobilization of actin from stress fibers in favor of filopodia formation.
Vetterkind S; Miki H; Takenawa T; Klawitz I; Scheidtmann KH; Preuss U
J Biol Chem; 2002 Jan; 277(1):87-95. PubMed ID: 11687573
[TBL] [Abstract][Full Text] [Related]
29. A novel anti-WIP monoclonal antibody detects an isoform of WIP that lacks the WASP binding domain.
Koduru S; Massaad M; Wilbur C; Kumar L; Geha R; Ramesh N
Biochem Biophys Res Commun; 2007 Feb; 353(4):875-81. PubMed ID: 17207458
[TBL] [Abstract][Full Text] [Related]
30. Disease-associated missense mutations in the EVH1 domain disrupt intrinsic WASp function causing dysregulated actin dynamics and impaired dendritic cell migration.
Worth AJ; Metelo J; Bouma G; Moulding D; Fritzsche M; Vernay B; Charras G; Cory GO; Thrasher AJ; Burns SO
Blood; 2013 Jan; 121(1):72-84. PubMed ID: 23160469
[TBL] [Abstract][Full Text] [Related]
31. Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae.
Rajmohan R; Raodah A; Wong MH; Thanabalu T
FEMS Yeast Res; 2009 Dec; 9(8):1226-35. PubMed ID: 19817875
[TBL] [Abstract][Full Text] [Related]
32. Toca-1 mediates Cdc42-dependent actin nucleation by activating the N-WASP-WIP complex.
Ho HY; Rohatgi R; Lebensohn AM; Le Ma ; Li J; Gygi SP; Kirschner MW
Cell; 2004 Jul; 118(2):203-16. PubMed ID: 15260990
[TBL] [Abstract][Full Text] [Related]
33. Platelet-associated IgAs and impaired GPVI responses in platelets lacking WIP.
Falet H; Marchetti MP; Hoffmeister KM; Massaad MJ; Geha RS; Hartwig JH
Blood; 2009 Nov; 114(21):4729-37. PubMed ID: 19692704
[TBL] [Abstract][Full Text] [Related]
34. Wiskott-Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma.
Menotti M; Ambrogio C; Cheong TC; Pighi C; Mota I; Cassel SH; Compagno M; Wang Q; Dall'Olio R; Minero VG; Poggio T; Sharma GG; Patrucco E; Mastini C; Choudhari R; Pich A; Zamo A; Piva R; Giliani S; Mologni L; Collings CK; Kadoch C; Gambacorti-Passerini C; Notarangelo LD; Anton IM; Voena C; Chiarle R
Nat Med; 2019 Jan; 25(1):130-140. PubMed ID: 30510251
[TBL] [Abstract][Full Text] [Related]
35. Waltzing with WASP.
Ramesh N; Antón IM; Martínez-Quiles N; Geha RS
Trends Cell Biol; 1999 Jan; 9(1):15-9. PubMed ID: 10087612
[TBL] [Abstract][Full Text] [Related]
36. The WH1 and EVH1 domains of WASP and Ena/VASP family members bind distinct sequence motifs.
Zettl M; Way M
Curr Biol; 2002 Sep; 12(18):1617-22. PubMed ID: 12372256
[TBL] [Abstract][Full Text] [Related]
37. WASP suppresses the growth defect of Saccharomyces cerevisiae las17Delta strain in the presence of WIP.
Rajmohan R; Meng L; Yu S; Thanabalu T
Biochem Biophys Res Commun; 2006 Apr; 342(2):529-36. PubMed ID: 16488394
[TBL] [Abstract][Full Text] [Related]
38. A complex of Wiskott-Aldrich syndrome protein with mammalian verprolins plays an important role in monocyte chemotaxis.
Tsuboi S
J Immunol; 2006 Jun; 176(11):6576-85. PubMed ID: 16709815
[TBL] [Abstract][Full Text] [Related]
39. The Wiskott-Aldrich syndrome protein-interacting protein (WIP) binds to the adaptor protein Nck.
Antón IM; Lu W; Mayer BJ; Ramesh N; Geha RS
J Biol Chem; 1998 Aug; 273(33):20992-5. PubMed ID: 9694849
[TBL] [Abstract][Full Text] [Related]
40. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
